SK
Sanjay Kukreja
About Sanjay Kukreja
Data last updated:
Sanjay Kukreja is a Director at Intas Pharmaceuticals Limited (since 2020), Director at Hero Fincorp Limited (since 2016) and Director at Theobroma Foods Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Financial Services and Travel and Hospitality. The 4 current companies with reported revenue have a combined latest revenue of ₹32,057 Cr; the largest is Intas Pharmaceuticals Limited at ₹21,241 Cr (FY 2025). Earlier, Sanjay Kukreja was a Director at Gebbs Healthcare Solutions Private Limited (2018–2024) and Director at Credila Financial Services Limited (2024) and 9 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 May 2020 | 1985 | ₹21,241 Cr (FY 2025) | Active | |
| Director | 15 Sep 2016 | 1991 | ₹9,903 Cr (FY 2025) | Active | |
| Director | 12 Aug 2025 | 2004 | ₹756 Cr (FY 2026) | Active | |
| Designated Partner | 29 Feb 2016 | 2016 | ₹157 Cr (FY 2020) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Dec 2018 | 2004 | ₹1,967 Cr (FY 2025) | Active | |
| Director | 20 Mar 2024 | 2006 | ₹4,726 Cr (FY 2025) | Active | |
| Director | 28 Jan 2013 | 1990 | ₹5,484 Cr (FY 2025) | Active | |
| Nominee Director | 09 Sep 2005 | 1979 | ₹41,859 Cr (FY 2025) | Active | |
| Director | 04 Feb 2012 | ||||
| Nominee Director | 27 Mar 2019 | 2012 | ₹2,419 Cr (FY 2022) | Amalgamated | |
| Nominee Director | 18 Jul 2006 | 1997 | ₹3,943 Cr (FY 2025) | Active | |
| Director | 15 May 2007 | 1984 | Under Liquidation | ||
| Director | 21 May 2012 | 2012 | ₹21.8 Lakh (FY 2023) | Dissolved Under Section 59(8) |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Kukreja
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Kukreja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Kukreja
Sanjay Kukreja currently holds 4 directorships: Intas Pharmaceuticals Limited (Director, since 21 May 2020, revenue ₹21,241 Cr (FY 2025)); Hero Fincorp Limited (Director, since 15 Sep 2016, revenue ₹9,903 Cr (FY 2025)); Theobroma Foods Private Limited (Director, since 12 Aug 2025, revenue ₹756 Cr (FY 2026)); Chryscapital Advisors Llp (Designated Partner, since 29 Feb 2016, revenue ₹157 Cr (FY 2020)).
Sanjay Kukreja was first appointed on 09 Sep 2005 as Nominee Director at Shriram Finance Limited. The most recent appointment on record is 12 Aug 2025 at Theobroma Foods Private Limited.
The 4 current companies of Sanjay Kukreja that report revenue have a combined latest revenue of ₹32,057 Cr: Intas Pharmaceuticals Limited ₹21,241 Cr (FY 2025); Hero Fincorp Limited ₹9,903 Cr (FY 2025); Theobroma Foods Private Limited ₹756 Cr (FY 2026); Chryscapital Advisors Llp ₹157 Cr (FY 2020).
Sanjay Kukreja held 11 earlier board appointments: Gebbs Healthcare Solutions Private Limited (Director, 03 Dec 2018 to 22 Nov 2024); Credila Financial Services Limited (Director, 20 Mar 2024 to 11 Nov 2024); Birlasoft Limited (Director, 28 Jan 2013 to 15 Sep 2017); Shriram Finance Limited (Nominee Director, 09 Sep 2005 to 30 Mar 2009); Ramkrishna Casting Solutions Limited (Director, 04 Feb 2012 to 19 Aug 2013); and 6 more.
The current boards of Sanjay Kukreja's companies include Archana Ravindrarai Dholakia (Intas Pharmaceuticals Limited), Binish Hasmukh Chudgar (Intas Pharmaceuticals Limited), Hasmukh Chudgar (Intas Pharmaceuticals Limited), Jayesh Shantilal Shah (Intas Pharmaceuticals Limited), Jitesh Kishorekumar Gadhia (Intas Pharmaceuticals Limited), Manoj Narayanan Nair (Intas Pharmaceuticals Limited), among others.